HDII (Hypertension Diagnostics) Equity-to-Asset: -3.72 (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Equity-to-Asset?

Hypertension Diagnostics HDII -99.00% Equity-to-Asset is -3.72 as of Sep. 2019.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hypertension Diagnostics's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $-4.75 Mil. Hypertension Diagnostics's Total Assets for the quarter that ended in Sep. 2019 was $1.28 Mil.

The historical rank and industry rank for Hypertension Diagnostics's Equity-to-Asset or its related term are showing as below:

HDII's Equity-to-Asset is not ranked *
in the Diversified Financial Services industry.
Industry Median: 0.9
* Ranked among companies with meaningful Equity-to-Asset only.

Hypertension Diagnostics  (OTCPK:HDII) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Hypertension Diagnostics Equity-to-Asset Related Terms

Hypertension Diagnostics Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Equity-to-Asset Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 -0.22 -3.04 -3.11 -3.72

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.11 -3.72 -3.72 -3.72 -3.72

HDII vs ESTRF, OCLN, PTOI: Equity-to-Asset Comparison

For the Shell Companies subindustry, Hypertension Diagnostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics Equity-to-Asset vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's Equity-to-Asset falls into.


Hypertension Diagnostics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hypertension Diagnostics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Equity to Asset (A: Dec. 2018 )=Total Stockholders Equity/Total Assets
=-4.752/1.278
=-3.72

Hypertension Diagnostics's Equity to Asset Ratio for the quarter that ended in Sep. 2019 is calculated as

Equity to Asset (Q: Sep. 2019 )=Total Stockholders Equity/Total Assets
=-4.752/1.278
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -3.72 mean?
Hypertension Diagnostics (HDII) has a Equity-to-Asset of -3.72 as of Sep. 2019. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Equity-to-Asset too high?
Hypertension Diagnostics' current Equity-to-Asset is -3.72.
How does Hypertension Diagnostics' Equity-to-Asset compare to ESTRF and OCLN?
Hypertension Diagnostics' Equity-to-Asset of -3.72 can be compared against companies in the Diversified Financial Services industry. The industry median Equity-to-Asset is 0.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Diversified Financial Services company?
The median Equity-to-Asset among Diversified Financial Services companies is 0.90, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Hypertension Diagnostics and its competitors. For the Diversified Financial Services industry, the median Equity-to-Asset is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypertension Diagnostics's current Equity-to-Asset is -3.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Equity-to-Asset of -3.72. The current Equity-to-Asset is -3.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Equity-to-Asset is -3.72 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.